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ABSTRACT
The characteristics of spontaneous aerobic Gram-
negative bacillary meningitis (AGNBM) were
determined in 40 adults requiring admission to
an intensive care unit (ICU) during a 16-year
period in ten French ICUs. Eight infections were
hospital-acquired and most patients had predis-
posing factors, mainly chronic alcoholism and an
immunocompromised status. Three immunosup-
pressed patients had disseminated strongyloidia-
sis. Gram’s stain, cerebrospinal fluid and blood
cultures were positive for 85%, 98% and 80% of
cases, respectively. Escherichia coli (57%) and
Klebsiella pneumoniae (17%) were the most fre-
quent pathogens. In-ICU mortality was 38%.
Spontaneous AGNBM is a rare complication of
bacteraemia in adults. The severity of predispo-
sing underlying diseases might explain the poor
prognosis despite appropriate antimicrobial
therapy.
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Spontaneous aerobic Gram-negative bacillary
meningitis (AGNBM) in adults is uncommon in
Western countries, having been reported in only
4% and 0.7% of patients with community-
acquired bacterial meningitis in the USA and
Europe, respectively [1–4]. In contrast, AGNBM,
especially that caused by Klebsiella pneumoniae, is
more frequent in some other areas, e.g., Taiwan
[5]. Most studies dealing with AGNBM include
patients with post-trauma or neurosurgical men-
ingitis and spontaneous episodes, without delin-
eating clearly among the specific characteristics of
the latter [6–9]. The present study determined the
clinical characteristics and outcome of sponta-
neous AGNBM in adults requiring admission to
intensive care units (ICUs) in France. The charts
of consecutive patients aged > 16 years with
AGNBM who were admitted to ten ICUs in
France between January 1988 and July 2003 were
analysed retrospectively. Patients were included
if they had cerebrospinal fluid pleocytosis
(> 10 cells ⁄ lL) with a predominance of polymor-
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phonuclear cells, and positive cerebrospinal fluid
or blood cultures containing Gram-negative
bacilli. Episodes caused by Haemophilus influenzae,
or those associated with recent (< 1 month) head
trauma or neurosurgical procedures, were ex-
cluded. Predisposing factors were recorded and
the severity of any underlying medical condi-
tion(s) was evaluated according to the criteria of
McCabe and Jackson [10]. Meningitis was further
classified as community- or hospital-acquired
according to the 1988 guidelines from the CDC
[11]. The retrospective design of the study meant
that the primary site of infection was only
presumptive for most patients.
Initial antibiotic therapy was considered appro-
priate when the pathogen was susceptible to the
chosen antibiotic, provided that the regimen
included a third-generation cephalosporin (cefo-
taxime or ceftriaxone for Enterobacteriaceae; ceft-
azidime or cefepime for Pseudomonas aeruginosa),
a carbapenem or high-dose (‡ 1200 mg ⁄day)
ciprofloxacin. Categorical variables were
expressed as percentages and continuous varia-
bles as medians (25th and 75th percentiles).
During the 16-year period, 40 patients diag-
nosed with spontaneous AGNBM, including 32
community- and eight hospital-acquired epi-
sodes, were admitted to the participating ICUs.
These 40 patients represented 2% of the cases of
bacterial meningitis diagnosed during the study
period. Demographic characteristics and under-
lying diseases that might have predisposed
patients to meningitis are summarised in
Table 1. Seven patients from endemic areas
had intestinal parasites, including strongyloidi-
asis in the case of five patients (three of whom
were immunocompromised and had dissemin-
ated strongyloidiasis). Salient clinical features
and cerebrospinal fluid characteristics are sum-
marised in Tables 1 and 2, respectively. Blood
cultures from 32 (80%) patients yielded Gram-
negative bacilli.
The causative microorganisms of meningitis
were identified as Escherichia coli (n = 23), K.
pneumoniae (n = 7), Klebsiella oxytoca (n = 2), Ps.
aeruginosa (n = 3), Proteus mirabilis (n = 2), Pasteu-
rella multocida, Salmonella D, Serratia marcescens
and Acinetobacter haemolyticus (all n = 1). One
patient was co-infected with K. pneumoniae and
Prot. mirabilis. Nosocomial cases were caused by
Ps. aeruginosa (n = 3), E. coli (n = 2), K. oxytoca
(n = 1), S. marcescens and A. haemolyticus (one
Table 2. Initial cerebrospinal fluid results for 40 adults
with spontaneous Gram-negative bacillary meningitis.
Results concerning leukocyte counts and protein concen-
trations were available for only 39 patients, and results
concerning glucose concentration were available for only




(25th percentile; 75th percentile) n (%)
Leukocytes ⁄mm3 3000 (325; 7555)
5–99 3 ⁄ 39 (8)
100–999 10 ⁄ 39 (26)
1000–4999 10 ⁄ 39 (26)
5000–9999 8 ⁄ 39 (21)
‡ 10 000 8 ⁄ 39 (21)
Protein (g ⁄L) 3.6 (1.8; 7)
0–0.99 2 ⁄ 39 (5)
1–4.99 23 ⁄ 39 (59)
5–9.99 10 ⁄ 39 (26)
‡ 10 4 ⁄ 39 (10)
Glucose (mmol ⁄L) 0.3 (0.1; 2)
0–0.99 23 ⁄ 37 (62)
1–2.99 7 ⁄ 37 (19)
‡ 3 7 ⁄ 37 (19)
Gram’s stain-positive 34 ⁄ 40 (85)
Culture-positive 39 ⁄ 40 (98)
Table 1. Demographic characteristics, clinical features and
predisposing factors upon hospital admission (patients






Age, years, median (Q1; Q3) 56 (41; 76)
Males ⁄ females, n 20 ⁄ 20
African or Caribbean origin, n (%) 5 (12.5)
McCabe and Jackson classification, n (%)
Non-fatal underlying disease 24 (60)
Ultimately fatal underlying disease 7 (17.5)
Rapidly fatal underlying disease 9 (22.5)
Underlying disease, n (%) 30 (75)
Chronic alcoholism 13 (33)
Cirrhosis 9 (23)
Immunosuppressive therapy 4 (10)
Infection with human immunodeficiency virus 3 (7.5)
Agammaglobulinaemia or hypogammaglobulinaemia 2 (5)
Asplenia 1 (2.5)
Malignancy 7 (18)
Diabetes mellitus 7 (18)
Remote head trauma 4 (10)
Previous episode of bacterial meningitis 3 (7.5)
Signs and symptoms upon presentation
Body temperature, C, median (Q1; Q3) 38.6 (37.8; 39.4)
Triad of fever, neck stiffness and change in
mental status, n (%)
24 (60)
Altered consciousness, n (%) 36 (90)
Score on Glasgow Coma Scalea, median (Q1; Q3) 12 (9; 14)
< 8 (indicating coma) 6 (15)
Focal neurological deficit, n (%) 12 (30)
Hemiparesis, n (%) 12 (30)
Cranial nerve palsy, n (%) 2b (5)
Generalised seizures, n (%) 12 (30)
SAPS IIc, median (Q1; Q3) 40 (30; 56)
Mechanical ventilation, n (%) 28 (70)
Inotropic support for septic shock, n (%) 16 (40)
aGCS: Glasgow coma scale [17].
bTwo patients had both hemiparesis and cranial nerve palsy.
cSAPS II: simplified acute physiology score [18].
Q1, 25th percentile; Q3, 75th percentile.
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patient each). All Enterobacteriaceae were sus-
ceptible to cefotaxime and to fluoroquinolones,
but 40% of E. coli isolates were resistant to
aminopenicillins.
Seven patients had intestinal parasitosis. For
seven other patients, a gastrointestinal origin was
suspected for the following reasons: previously
diagnosed haemorrhagic rectocolitis (n = 1),
abdominal pain and ⁄ or diarrhoea (n = 4), con-
comitant acute cholecystitis (n = 1), and Salmon-
ella D bacteraemia (n = 1). Three of these latter
seven patients underwent abdominal ultrasono-
graphy or computed tomography scan, which did
not detect specific lesions. Other presumed por-
tals of entry were the urinary tract (n = 14) and
dental (n = 1) or otitic (n = 1) lesions, but the
portal was unknown for ten patients. A computed
tomography scan was performed for 35 patients
and showed abnormalities in five cases: diffuse
oedema (n = 3), and parietal or occipital area
of low attenuation consistent with ischaemia
(n = 1 each).
The most frequent initial therapeutic regimens
were: a third-generation cephalosporin alone
(n = 7) or in combination with an aminoglycoside
(n = 13), a fluoroquinolone (n = 3) or an amino-
penicillin (n = 3); an aminopenicillin alone
(n = 5); or a fluoroquinolone combined with an
aminoglycoside (n = 3). Initial antibiotic therapy
was appropriate for 33 patients and, for the
remaining seven patients, was switched to an
appropriate agent after 24 h. Among the latter
group, five patients received an aminopenicillin
alone, although the causative microorganisms
were resistant in four cases (i.e., K. oxytoca, S.
marcescens, E. coli and Ps. aeruginosa), and two
patients received inappropriate antimicrobial
agents for resistant Ps. aeruginosa. Only four
patients received adjunctive steroid therapy. The
overall in-hospital mortality rate was 38%
(15 ⁄ 40). Among the 25 survivors, five (20%) had
neurological sequelae at hospital discharge.
To the best of our knowledge, this is the largest
reported series of patients with severe spon-
taneous meningitis caused by Gram-negative
bacilli. In agreement with earlier reports [5–9],
most of these patients had one or more predis-
posing factors, e.g., immunocompromised status,
diabetes or alcoholism. A relatively high number
of patients had intestinal parasitosis, and three
patients had disseminated strongyloidiasis upon
admission to the ICU. All patients with intestinal
parasitosis were seen in the same Parisian
hospital, which caters to a large population of
African and French individuals from overseas
territories. Spontaneous AGNBM in association
with strongyloidiasis hyper-infection has been
documented previously [12]. Meningitis occurs
secondary to seeding of the meninges during
persistent or recurrent episodes of bacteraemia
associated with the migration of infective larvae.
The larvae may also carry enteric organisms on
their surfaces, or within their own gastrointesti-
nal tracts, as they invade the meninges [13].
However, with the exception of patients with
strongyloidiasis hyperinfection, the relationship
between intestinal parasitosis and AGNBM is
unclear.
Third-generation cephalosporins are consid-
ered to be a major therapeutic advance in the
treatment of AGNBM [5,14] and should be includ-
ed in the first-line antibiotic regimen for patients
with suspected AGNBM. Ceftazidime or cefe-
pime, in combination with an aminoglycoside,
should be prescribed when Ps. aeruginosa infection
is suspected, especially for patients with hospital-
acquired meningitis [15]. Despite the early use of a
third-generation cephalosporin for most of these
patients, there was a mortality rate of 38%,
comparable to that usually reported for pneumo-
coccal meningitis, which is far more common [16].
Spontaneous AGNBM in adults is a rare com-
plication of bacteraemia, occurring mainly in
debilitated patients. Among predisposing factors,
strongyloidiasis should be suspected in patients
who have lived previously in an endemic area.
The poor outcome can be explained, at least in
part, by the severity of the underlying condi-
tion(s) and ⁄ or predisposing factors.
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ABSTRACT
This study describes the influence of hepatitis C
virus (HCV) and hepatitis G virus (HGV) co-
infection on CD4 cell count decline and plasma
human immunodeficiency virus (HIV) viral load
in HIV-infected patients during a 1-year period
following interruption of highly active anti-retro-
viral therapy (HAART) guided by CD4 count.
CD4 cell count decline and plasma HIV viral load
did not differ between HIV mono-infected pa-
tients and those patients co-infected with HCV
and HGV. HCV genotype 1 had no apparent
influence on the cellular and viral dynamics in
HIV-infected patients compared with other HCV
genotypes, although the unbalanced groups make
larger studies desirable.
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